Intramuscular administration of drugs

Drug-drug interactions after oral and intramuscular/subcutaneous administration of cabotegravir, rilpivirine and lenacapavir. Intramuscular (IM) or

Intramuscular injection: Intramuscular administration must be restricted to exceptional cases where neither oral nor intravenous administration is feasible. It

Food and Drug Administration. Abilify Asimtufi (aripiprazole) extended-release injectable suspension, for intramuscular use. Food and Drug Administration. Abilify Maintena (aripiprazole) for extended-release intramuscular suspension, for intramuscular use. Food and Drug Administration. Abilify Mycite (aripiprazole tablets with sensor), for oral

dose (by inhalation) up to the maximum dose indicated above. S4 intramuscular administration. If intramuscular administration is

This chapter describes intramuscular drug administration. In contrast to intravascular administration, other parenteral dosing procedures, such as intramuscular administration, often cause the formation of a drug depot. Intramuscularly injected drug solvent distributes rapidly in the fascial planes or connective tissue surrounding the muscles.

intramuscular administration. If intramuscular administration is suspected, the washout periods for the intramuscular route should be observed.

administration. If intramuscular administration is suspected, the washout periods for the intramuscular route should be observed.

dose (by inhalation) up to the maximum dose indicated above. S4 intramuscular administration. If intramuscular administration is

intramuscular administration. If intramuscular administration is suspected, the washout periods for the intramuscular route should be observed.